Viji Shridhar

9.9k total citations · 1 hit paper
126 papers, 7.2k citations indexed

About

Viji Shridhar is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Viji Shridhar has authored 126 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 32 papers in Cancer Research and 28 papers in Oncology. Recurrent topics in Viji Shridhar's work include Ovarian cancer diagnosis and treatment (19 papers), Epigenetics and DNA Methylation (15 papers) and Cerebrovascular and genetic disorders (13 papers). Viji Shridhar is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Epigenetics and DNA Methylation (15 papers) and Cerebrovascular and genetic disorders (13 papers). Viji Shridhar collaborates with scholars based in United States, Italy and Japan. Viji Shridhar's co-authors include Jeremy Chien, Jeremy C. Smith, Ramandeep Rattan, Julie Staub, Shailendra Giri, Jacie Maguire, Rondell P. Graham, Ashwani Khurana, Lewis R. Roberts and Scott H. Kaufmann and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Viji Shridhar

124 papers receiving 7.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration

2006 609 citations Jeremy Chien, Viji Shridhar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Viji Shridhar United States	47	4.5k	1.4k	1.4k	1.2k	647	126	7.2k
Jeremy Chien United States	39	2.9k 0.6×	824 0.6×	943 0.7×	777 0.6×	377 0.6×	115	4.6k
Laura E. Benjamin United States	38	6.9k 1.5×	2.6k 1.9×	2.8k 2.0×	1.1k 0.9×	320 0.5×	70	10.8k
Olle Larsson Sweden	51	4.4k 1.0×	2.5k 1.8×	1.3k 0.9×	654 0.5×	412 0.6×	212	8.5k
Grazia Ambrosini United States	27	4.8k 1.1×	2.2k 1.6×	743 0.5×	692 0.6×	386 0.6×	48	6.8k
Roseline Godbout Canada	44	4.9k 1.1×	1.7k 1.2×	1.5k 1.1×	439 0.4×	1.1k 1.7×	132	6.9k
Marc Vooijs Netherlands	45	4.9k 1.1×	2.0k 1.5×	1.4k 1.0×	590 0.5×	1.1k 1.7×	108	8.0k
John K. Cowell United States	57	7.0k 1.5×	2.2k 1.6×	1.6k 1.2×	1.6k 1.3×	1.9k 2.9×	302	11.3k
Zhengping Zhuang United States	63	4.9k 1.1×	2.8k 2.0×	4.0k 2.9×	604 0.5×	831 1.3×	321	12.3k
Giuseppe Viglietto Italy	48	5.4k 1.2×	2.3k 1.7×	1.6k 1.1×	526 0.4×	663 1.0×	150	8.2k
Per Guldberg Denmark	53	7.3k 1.6×	3.2k 2.3×	1.5k 1.1×	790 0.6×	1.1k 1.6×	195	10.9k

Countries citing papers authored by Viji Shridhar

Since Specialization

Citations

This map shows the geographic impact of Viji Shridhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viji Shridhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viji Shridhar more than expected).

Fields of papers citing papers by Viji Shridhar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viji Shridhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viji Shridhar. The network helps show where Viji Shridhar may publish in the future.

Co-authorship network of co-authors of Viji Shridhar

This figure shows the co-authorship network connecting the top 25 collaborators of Viji Shridhar. A scholar is included among the top collaborators of Viji Shridhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viji Shridhar. Viji Shridhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ray, Upasana, Prabhu Thirusangu, Ling Jin, et al.. (2023). PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction. Oncogene. 42(37). 2725–2736. 7 indexed citations

Tang, Xiaojia, Jianning Song, Upasana Ray, et al.. (2022). DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model. NAR Cancer. 4(3). zcac022–zcac022. 1 indexed citations

Ray, Upasana, et al.. (2022). Exploiting LRRC15 as a Novel Therapeutic Target in Cancer. Cancer Research. 82(9). 1675–1681. 31 indexed citations

Ray, Upasana, Debarshi Roy, Ling Jin, et al.. (2021). Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization. Journal of Experimental & Clinical Cancer Research. 40(1). 182–182. 12 indexed citations

Dasari, Subramanyam, Tommaso Grassi, Daniel W. Visscher, et al.. (2020). Signals from the Metastatic Niche Regulate Early and Advanced Ovarian Cancer Metastasis through miR-4454 Downregulation. Molecular Cancer Research. 18(8). 1202–1217. 12 indexed citations

Mondal, Susmita, Debarshi Roy, Sayantani Sarkar Bhattacharya, et al.. (2018). Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers. International Journal of Cancer. 144(1). 178–189. 120 indexed citations

Wentzensen, Nicolas, Jamie N. Bakkum‐Gamez, Jonathan Keith Killian, et al.. (2014). Discovery and validation of methylation markers for endometrial cancer. International Journal of Cancer. 135(8). 1860–1868. 55 indexed citations

Ohta, Tsuyoshi, Yusuke Oji, Haruo Sugiyama, et al.. (2014). The Wilms' Tumor Gene WT1 − 17AA/− KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer Model. Translational Oncology. 7(5). 580–589. 10 indexed citations

Zhang, Wei, Takayo Ota, Viji Shridhar, et al.. (2013). Network-based Survival Analysis Reveals Subnetwork Signatures for Predicting Outcomes of Ovarian Cancer Treatment. PLoS Computational Biology. 9(3). e1002975–e1002975. 127 indexed citations

10.

Khurana, Ashwani, Peng Liu, Pasquale Mellone, et al.. (2011). HSulf-1 Modulates FGF2- and Hypoxia-Mediated Migration and Invasion of Breast Cancer Cells. Cancer Research. 71(6). 2152–2161. 46 indexed citations

11.

Beleford, Daniah, Zhixue Liu, Ramandeep Rattan, et al.. (2010). Methylation Induced Gene Silencing of HtrA3 in Smoking-Related Lung Cancer. Clinical Cancer Research. 16(2). 398–409. 41 indexed citations

12.

He, Xiaoping, Takayo Ota, Peng Liu, et al.. (2010). Downregulation of HtrA1 Promotes Resistance to Anoikis and Peritoneal Dissemination of Ovarian Cancer Cells. Cancer Research. 70(8). 3109–3118. 69 indexed citations

13.

Liu, Peng, Ashwani Khurana, Ramandeep Rattan, et al.. (2009). Regulation of HSulf-1 Expression by Variant Hepatic Nuclear Factor 1 in Ovarian Cancer. Cancer Research. 69(11). 4843–4850. 40 indexed citations

14.

Narita, Keishi, Jeremy Chien, Sally A. Mullany, et al.. (2007). Loss of HSulf-1 Expression Enhances Autocrine Signaling Mediated by Amphiregulin in Breast Cancer. Journal of Biological Chemistry. 282(19). 14413–14420. 66 indexed citations

15.

Narita, Keishi, Julie Staub, Jeremy Chien, et al.. (2006). HSulf-1 Inhibits Angiogenesis and Tumorigenesis In vivo. Cancer Research. 66(12). 6025–6032. 119 indexed citations

16.

Shridhar, Viji, Keith C. Bible, Julie Staub, et al.. (2001). Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.. PubMed. 61(10). 4258–65. 74 indexed citations

17.

Shridhar, Ravi, Viji Shridhar, Xiaohong Wang, et al.. (1996). Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors.. PubMed. 56(19). 4347–50. 64 indexed citations

18.

Liu, Wanguo, Viji Shridhar, Zheng Song, et al.. (1993). The isolation of a yeast artificial chromosome (YAC) contig extending for 2 megabases in the vicinity of the Von Hippel Lindau disease gene. Human Molecular Genetics. 2(8). 1177–1182. 7 indexed citations

19.

Joseph, Anthony J., Viji Shridhar, Robert M. Gemmill, et al.. (1993). Cloning and characterization of the human t(3;6)(p14;p11) translocation breakpoint associated with hematologic malignancies. Cancer Genetics and Cytogenetics. 71(1). 15–21. 14 indexed citations

20.

Ginzinger, David G., Viji Shridhar, Antonio Baldini, et al.. (1992). The human loci DNF15S2 and D3S94 have a high degree of sequence similarity to acyl-peptide hydrolase and are located at 3p21.3.. PubMed. 50(4). 826–33. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact